Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Epidemiol Infect ; 140(2): 299-310, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21470441

RESUMEN

Diversity within Shigella dysenteriae (n=40) and Shigella boydii (n=30) isolates from children living in Egypt aged <5 years was investigated. Shigella-associated diarrhoea occurred mainly in summer months and in children aged <3 years, it commonly presented with vomiting and fever. Serotypes 7 (30%), 2 (28%), and 3 (23%) accounted for most of S. dysenteriae isolates; 50% of S. boydii isolates were serotype 2. S. dysenteriae and S. boydii isolates were often resistant to ampicillin, chloramphenicol and tetracycline (42%, 17%, respectively), although resistance varied among serotypes. Pulsed-field gel electrophoresis separated the isolates into distinct clusters correlating with species and serotype. Genetic differences in trimethoprim/sulfamethoxazole and ß-lactam-encoding resistance genes were also evident. S. dysenteriae and S. boydii are genetically diverse pathogens in Egypt; the high level of multidrug resistance associated with both pathogens and resistance to the most available inexpensive antibiotics underlines the importance of continuing surveillance.


Asunto(s)
Farmacorresistencia Bacteriana , Disentería Bacilar/epidemiología , Shigella boydii/efectos de los fármacos , Shigella boydii/aislamiento & purificación , Shigella dysenteriae/efectos de los fármacos , Shigella dysenteriae/genética , Antibacterianos/farmacología , Preescolar , Disentería Bacilar/microbiología , Egipto/epidemiología , Electroforesis en Gel de Campo Pulsado , Heces/microbiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Filogenia , Reacción en Cadena de la Polimerasa , Shigella boydii/clasificación , Shigella boydii/genética , Shigella dysenteriae/clasificación , Shigella dysenteriae/aislamiento & purificación , Sulfametoxazol/farmacología , beta-Lactamas/farmacología
2.
Egypt J Immunol ; 11(2): 183-9, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-16734132

RESUMEN

We measured interferon-gamma (IFN-gamma) in supernatant of peripheral blood mononuclear cell (PBMC) cultures stimulated with mycobacterial antigens. The study included ten children with newly diagnosed active pulmonary tuberculosis (TB), ten with inactive TB and 8 healthy controls. IFN-gamma was quantified by ELISA. Antigen stimulated PBMCs produced IFN-gamma at significantly higher levels than the background levels of nonstimulated cultures. Following specific antigen stimulation in vitro with TB bacilli, the PBMCs from patients with active and inactive TB produced significantly higher levels of IFN-gamma (433.15+/-119.80 and 420.64+/-131.52 respectively) than controls (241.2+/-119.74), (P< 0.001). However, no significant difference was found between active and inactive TB patients. In conclusion, estimation of specific IFN-gamma production by PBMC may be a useful immunological tool for diagnosis of childhood tuberculosis.


Asunto(s)
Interferón gamma/análisis , Leucocitos Mononucleares/inmunología , Mycobacterium tuberculosis/inmunología , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/inmunología , Adolescente , Niño , Preescolar , Femenino , Humanos , Pruebas Inmunológicas/métodos , Interferón gamma/metabolismo , Leucocitos Mononucleares/metabolismo , Masculino , Valor Predictivo de las Pruebas , Tuberculosis Pulmonar/sangre
3.
J Health Popul Nutr ; 18(1): 33-8, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11014768

RESUMEN

While Campylobacter, Salmonella, and Shigella remain major contributors to acute enteric infections, few studies on these pathogens have been conducted in Egypt. From January 1986 to December 1993, 869 Salmonella, Shigella and Campylobacter strains were isolated from stool specimens from 6,278 patients, presenting to the Abbassia Fever Hospital, Cairo, Egypt, with acute enteric infections. Salmonella predominated, totalling 465 isolates, followed by Shigella with 258 isolates, and Campylobacter with 146 isolates. Of the Shigella isolates, 124 were Shigella flexneri, 49 were S. sonnei, 47 were S. dysenteriae (mainly serotype 1, 2, and 3), and 38 were S. boydii. Campylobacter spp. comprised 92 Campylobacter jejuni and 54 C. coli isolates. Isolation of Salmonella was highest during the months of February-March, June-July, and October-November, while that of Shigella was maximal from July to October. Isolation of Campylobacter increased during May-June and again during August-October. Although Salmonella was sensitive to amikacin, aztreonam, ceftriaxone, and nalidixic acid, it was, however, resistant to erythromycin, streptomycin, ampicillin, chloramphenicol, and tetracycline. Shigella (> 80%) was sensitive to amikacin, ceftriaxone, cephalothin, sulphamethoxazole-trimethoprim (except S. sonnei), aztreonam, and nalidixic acid. Resistance (> 50%) was noted only for ampicillin, chloramphenicol, and tetracycline. C. jejuni and C. coli were resistant to cephalothin, aztreonam, and streptomycin. Some of the above antibiotics were employed to characterize the Egyptian isolates, but did not have any clinical utility in the treatment of diarrhoea. Significant differences (p < 0.05) were observed in the resistance profiles of Shigella and Salmonella between late 1980s and early 1990s. The results suggest the use of fluoroquinolones or a third-generation cephalosporin as an empirical treatment of enteric diseases. However, alternative control strategies, including the aggressive development of broadly protective vaccines, may be more effective approaches to curbing morbidity and mortality due to acute enteric infections.


Asunto(s)
Antibacterianos/farmacología , Infecciones Bacterianas/microbiología , Campylobacter/aislamiento & purificación , Diarrea/microbiología , Salmonella/aislamiento & purificación , Shigella/aislamiento & purificación , Adolescente , Adulto , Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/epidemiología , Campylobacter/efectos de los fármacos , Campylobacter/crecimiento & desarrollo , Niño , Preescolar , Diarrea/tratamiento farmacológico , Diarrea/epidemiología , Farmacorresistencia Microbiana , Egipto/epidemiología , Heces/microbiología , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Salmonella/efectos de los fármacos , Salmonella/crecimiento & desarrollo , Estaciones del Año , Shigella/efectos de los fármacos , Shigella/crecimiento & desarrollo
4.
J Clin Microbiol ; 34(5): 1216-9, 1996 May.
Artículo en Inglés | MEDLINE | ID: mdl-8727905

RESUMEN

The conservation of flagellin genes from thermophilic Campylobacter spp. strains isolated in Egypt was evaluated by a restriction fragment length polymorphism (RFLP) assay. The flaA and flaB genes were amplified from 59 independent clinical isolates and digested with EcoRI and PstI, and the resulting patterns were compared with each other and with previously described RFLP groups. The results indicate that the isolates fell into 14 groups for flaA and 11 groups for flaB, 9 of which have been described, and that considerable genetic variability exists among isolates belonging to the same LIO serogroup. In most cases, the flaB gene displayed the same RFLP pattern as that of the flaA gene of the same strain, although some variability was observed. The data suggest that more variability of flagellin genes exists within the LIO serogroups common to Campylobacter field isolates from Egypt than has previously been reported for North American isolates.


Asunto(s)
Campylobacter coli/genética , Campylobacter jejuni/genética , Flagelina/genética , Genes Bacterianos , Polimorfismo de Longitud del Fragmento de Restricción , Secuencia de Bases , Infecciones por Campylobacter/microbiología , Campylobacter coli/clasificación , Campylobacter coli/aislamiento & purificación , Campylobacter jejuni/clasificación , Campylobacter jejuni/aislamiento & purificación , Estudios de Casos y Controles , Niño , Secuencia Conservada , Diarrea/microbiología , Egipto , Humanos , Serotipificación , Especificidad de la Especie
5.
J Egypt Public Health Assoc ; 71(1-2): 149-60, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-17217005

RESUMEN

This report describes the resistance of 537 Salmonella typhi isolates identified in Egypt between 1990-1994. Results indicated a high isolation rate for multiple resistant S. typhi (> 71% of isolates collected in 1992-93), particularly to the three standard drug regimens of the clinically relevant antibiotics; ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole. This adds to the complexity and difficulty of treating infections caused by these organisms. Resistance of S. typhi was associated with a transferable 120 MD plasmid. The organism was sensitive to amikacin, aztreonam, cephalothin, ceftriaxone, gentamicin and nalidixic acid, suggesting the use of aztreonam and ceftriaxone as alternative therapeutic drugs for the treatment of multidrug-resistant S. typhi. These results may provide a clinically useful evaluation of the spread and acquisition of resistance among S. typhi strains in Egypt.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Salmonella typhi/efectos de los fármacos , Fiebre Tifoidea/tratamiento farmacológico , Egipto/epidemiología , Humanos , Incidencia , Pruebas de Sensibilidad Microbiana , Prevalencia , Medición de Riesgo , Factores de Riesgo , Fiebre Tifoidea/epidemiología , Fiebre Tifoidea/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...